Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [654]
News [1409]
Articles [231]
Editorials [9]
Conferences [81]
elearning [12]
The DNA damage response and cancer therapy
Dr Christopher Lord, The Institute of Cancer Research, London, UK
The DNA damage response and cancer therapy ( Dr Christopher Lord, The Institute of Cancer Research, London, UK )
6 Jan 2015
Aims and successes of the 2nd EurocanPlatform project translational research...
Christina von Gertten, Karolinska Institutet, Stockholm, Sweden
Aims and successes of the 2nd EurocanPlatform project translational research course ( Christina von Gertten, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015
Epigenome deregulation in cancer
Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon...
Epigenome deregulation in cancer ( Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France )
6 Jan 2015
Immunotherapy of cancer: recent progress and future challenges
Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden
Immunotherapy of cancer: recent progress and future challenges ( Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015
Reasons to attend the EurocanPlatform translational research course 2015
Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany
Reasons to attend the EurocanPlatform translational research course 2015 ( Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany )
6 Jan 2015
2nd EurocanPlatform translational research course is good for networking
Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal
2nd EurocanPlatform translational research course is good for networking ( Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal )
6 Jan 2015
Biobanking biological materials and linkage to clinical information
Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands
Biobanking biological materials and linkage to clinical information ( Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands )
6 Jan 2015
The role of health economics in cancer outcomes research
Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden
The role of health economics in cancer outcomes research ( Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden )
6 Jan 2015
Patient and political advocacy in women's cancers
Sarah Goltz - Founder of Sage Innovation
Patient and political advocacy in women's cancers ( Sarah Goltz - Founder of Sage Innovation )
18 Dec 2014
WHO guidelines on preventing and screening for cervical cancer
Dr Nathalie Broutet – World Health Organization, Geneva, Switzerland
WHO guidelines on preventing and screening for cervical cancer ( Dr Nathalie Broutet – World Health Organization, Geneva, Switzerland )
18 Dec 2014
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of...
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients
Prof Elizabeth Swisher - University of Washington, Washington, USA
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients ( Prof Elizabeth Swisher - University of Washington, Washington, USA )
27 Nov 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation